- Q1 revenue hit $396M, up 50% year-over-year — the 19th consecutive beat-and-raise quarter.
- FY26 guidance raised to $1.785B revenue (+37% y/y, +22% organic) and $397.3M adjusted EBITDA at a ~22% margin.
- Marigold acquisition integration is reportedly ahead of schedule, but synergy realization remains the key execution test.
EV/FY26 Revenue: 2.8x at ~$19/share
ZETA Stock: What the Numbers Actually Say
ZETA stock is pricing in a company that the market has not fully decided to trust. Q1 revenue came in at $396 million — a 50% year-over-year gain — and management lifted FY26 revenue guidance to $1.785 billion. That implies 37% total growth, with 22% coming organically. Adjusted EBITDA guidance landed at $397.3 million, implying a margin of roughly 22%.
Nineteen consecutive quarters of beating and raising is not noise. It is a pattern. Whether that pattern reflects conservative guidance or genuine demand acceleration is a question the income statement alone cannot answer.
At approximately $19 per share, ZETA trades at 2.8x EV/FY26 revenue and 12.5x EV/FY26 EBITDA. For a company growing revenue at 20%-plus organically, those multiples sit at the low end of comparable SaaS peers. The discount exists for a reason: the market is still assigning risk to integration costs, AI disruption of ad-tech business models, and cyclical ad spending exposure. The bulls argue the discount is too wide. The bears have not been proven right in 19 quarters, but they have not fully capitulated either.
The Marigold Variable
The Marigold acquisition is the single largest near-term variable for ZETA stock. Management says integration is ahead of plan. That is the company’s characterization — third-party verification of synergy realization is not yet available in the sourced materials.
What analysts are watching is sequential margin improvement. If Marigold synergies are real, adjusted EBITDA margins should expand quarter-over-quarter through FY26. If they stall, the 22% full-year EBITDA guide becomes a ceiling, not a floor. The $1.785B revenue target requires Marigold to contribute meaningfully; the organic growth rate alone does not close the gap.
The AI narrative is doing real commercial work here: proprietary data assets and growing average revenue per user are cited as drivers of customer expansion. But the specific ARPU figure is not disclosed in the sourced materials — a number that would clarify whether unit economics are improving or whether top-line growth is primarily volume-driven.
Zeta Global has now beaten and raised 19 straight quarters, and FY26 guidance implies a company growing faster than its multiple reflects. The 2.8x EV/revenue valuation looks undemanding against 20%-plus organic growth SaaS comps — unless Marigold integration stumbles or cyclical ad budgets compress. The unresolved question is not whether Q1 was good (it was). It is whether the $1.785B FY26 revenue target can be hit without margin sacrifice. Sequential EBITDA margin data over the next two quarters will be the clearest signal. Until then, the gap between the bull case and the current price is a function of execution confidence, not earnings trajectory.
Q2 and Q3 adjusted EBITDA margins — sequential expansion confirms Marigold synergies are materializing; stagnation puts the $397.3M FY26 EBITDA guide at risk.
Methodology: This brief uses TickerRead’s AI-assisted source-checking workflow and is built from public, source-linked market information. Methodology | Editorial Policy
Disclaimer: This post is for informational purposes only and does not constitute investment advice. All investment decisions and their outcomes are solely the responsibility of the reader.
Sources: Seeking Alpha, Pluang